@article{TLCR23045,
author = {Giulio Metro and Massimo Di Maio},
title = {Cons: should immunotherapy be incorporated in the treatment of oncogene-driven lung cancer?},
journal = {Translational Lung Cancer Research},
volume = {7},
number = {Suppl 3},
year = {2018},
keywords = {},
abstract = {We agree with dr. Addeo and dr. Banna when they emphasize that the biology of non-small cell lung cancer (NSCLC) is complex, and that a single biomarker is probably not exhaustive in order to optimally predict (either positively or negatively) the potential efficacy of immune checkpoint inhibitors.},
issn = {2226-4477}, url = {https://tlcr.amegroups.org/article/view/23045}
}